A detailed history of Westside Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Westside Investment Management, Inc. holds 2,068 shares of LLY stock, worth $1.55 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,068
Previous 2,268 8.82%
Holding current value
$1.55 Million
Previous $2.05 Billion 10.79%
% of portfolio
0.39%
Previous 0.47%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$772.14 - $960.02 $154,428 - $192,004
-200 Reduced 8.82%
2,068 $1.83 Billion
Q2 2024

Jul 17, 2024

SELL
$724.87 - $909.04 $5,798 - $7,272
-8 Reduced 0.35%
2,268 $2.05 Billion
Q1 2024

Apr 19, 2024

SELL
$592.2 - $792.28 $1,184 - $1,584
-2 Reduced 0.09%
2,276 $1.77 Billion
Q4 2023

Jan 12, 2024

SELL
$525.19 - $619.13 $103,987 - $122,587
-198 Reduced 8.0%
2,278 $1.33 Billion
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $70,421 - $97,086
-162 Reduced 6.14%
2,476 $1.33 Billion
Q1 2023

May 17, 2023

SELL
$310.63 - $364.82 $27,956 - $32,833
-90 Reduced 3.3%
2,638 $906 Million
Q4 2022

Jan 31, 2023

SELL
$321.55 - $374.67 $12,862 - $14,986
-40 Reduced 1.45%
2,728 $998,000
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $37,060 - $42,233
125 Added 4.73%
2,768 $895,000
Q1 2022

Apr 25, 2022

BUY
$234.69 - $291.66 $491,206 - $610,444
2,093 Added 380.55%
2,643 $756,000
Q1 2021

Apr 14, 2021

BUY
$164.32 - $212.72 $4,108 - $5,318
25 Added 4.76%
550 $102,000
Q4 2020

Jan 15, 2021

SELL
$130.46 - $172.63 $4,566 - $6,042
-35 Reduced 6.25%
525 $88,000
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $19,098 - $22,985
-140 Reduced 20.0%
560 $91,000
Q4 2018

Feb 05, 2019

SELL
$105.9 - $118.64 $10,590 - $11,864
-100 Reduced 12.5%
700 $81,000
Q3 2018

Nov 08, 2018

SELL
$85.86 - $107.31 $25,242 - $31,549
-294 Reduced 26.87%
800 $86.1 Million
Q2 2017

Aug 15, 2017

BUY
N/A
1,094
1,094 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.